Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 1, 2017 – Eli Lilly announced the FDA approval of Taltz (ixekizumab), for the treatment of adult patients with active psoriatic arthritis (PsA).
Return to publications